Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://www.ncbi.nlm.nih.gov/pubmed/25788949
http://dx.doi.org/10.1186/1710-1492-10-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://www.ncbi.nlm.nih.gov/pubmed/25788949
http://dx.doi.org/10.1186/1710-1492-10-55

Ejemplares similares